Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence

globenewswire.com
ALC Mentioned as a major company in the ophthalmic devices market, which is projected to grow. No specific sentiment for Alcon itself, but its inclusion in a growing market is neutral. JNJ Listed as a major company in the ophthalmic devices market, which is expected to grow. The article does not provide specific sentiment for Johnson & Johnson Vision Care. BLCO Included as a major company in the ophthalmic devices market, which is projected to grow. The article does not offer specific sentiment for Bausch + Lomb. BSX Listed as a major company in the cardiovascular devices market, which is projected to grow. The article does not provide specific sentiment for Boston Scientific Corporation. ABT Mentioned as a major company in the cardiovascular devices market, which is projected to grow. No specific sentiment for Abbott itself, but its inclusion in a growing market is neutral. MDT Listed as a major company in the cardiovascular devices market, which is projected to grow. The article does not provide specific sentiment for Medtronic. LIF Mentioned as a major company in the cardiovascular devices market, which is projected to grow. No specific sentiment for Edwards Lifesciences Corporation itself, but its inclusion in a growing market is neutral. CAH Listed as a major company in the cardiovascular devices market, which is projected to grow. The article does not provide specific sentiment for Cardinal Health. AZN Listed as a major company in the prostate cancer market, which is projected to grow. The article does not provide specific sentiment for AstraZeneca PLC. SNY Mentioned as a major company in the prostate cancer market, which is projected to grow. No specific sentiment for Sanofi-Aventis itself, but its inclusion in a growing market is neutral. TMO Listed as a major company in the prostate cancer market, which is projected to grow. The article does not provide specific sentiment for Thermo Fisher Scientific.

Urology Devices Market to Reach $58.63 Billion by 2031 with Robotic Urologic Surgery Systems Projected to Expand at a 10.31% CAGR, Reports Mordor Intelligence Hyderabad, India, April 20, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the urology devices market size is projected to increase from USD 39.65 billion in 2025 to USD 42.32 billion in 2026, and is anticipated to reach USD 58.63 billion by 2031, expanding at a CAGR of 6.74% during the 2026–2031 period, supported by the rising burden of urological disorders and increasing demand for advanced diagnostic and treatment solutions. Healthcare providers are increasingly adopting technologically advanced urology devices to improve procedural efficiency, patient outcomes, and recovery times.

The market is expanding as the incidence of conditions such as kidney stones, urinary tract infections, benign prostatic hyperplasia, and bladder disorders continues to rise globally. An aging population, which is more susceptible to urological conditions, is further contributing to increased demand for effective treatment solutions. The growing preference for minimally invasive and endoscopic procedures is encouraging the adoption of innovative devices, including laser systems, endoscopes, and robotic-assisted surgical platforms. Technological advancements are playing a significant role in shaping the urology devices market. Innovations in imaging systems, laser lithotripsy, and catheter-based treatments improve precision and reduce complications. Additionally, the integration of digital health technologies and improved device ergonomics is enhancing procedural outcomes and patient comfort. Expanding healthcare infrastructure and increasing awareness of early diagnosis and treatment are further supporting market growth.

Urology Devices Market Share by Region

Urology Devices Market Trends & Forecast

Growing Adoption of Minimally Invasive Procedures

Minimally invasive urological procedures are gaining popularity due to reduced hospital stays, faster recovery times, and lower risk of complications.

“This analysis reflects observed demand patterns and competitive activity in urology devices, presented with consistent assumptions and validation checks. Its transparent sourcing and balanced interpretation provide decision-makers with a more dependable basis for comparison than many alternative market reports” says Soumya Goud, Senior Research Manager, Mordor Intelligence.

Advancements in Laser and Robotic Technologies

The use of laser-based treatments and robotic-assisted surgeries is enhancing precision and improving clinical outcomes in urology procedures.

Urology Devices Market Segmentation Overview

By Product

• Instruments

• Dialysis Devices

• Endoscopes & Endovision Systems

• Lasers & Lithotripsy Devices

• Robotic Surgical Systems

• Urodynamic Systems

• Imaging & Navigation Devices

• Bladder Management Devices

• Other Instruments

• Consumables & Accessories

• Dialysis Consumables

• Guidewires & Urinary Catheters

• Stents (Ureteral & Urethral)

• Biopsy Devices

• Disposable Ureteroscopes

• Continence Care Products

• Other Consumables & Accessories

By Technology

• Minimally-Invasive Surgery Devices

• Robotic Urologic Surgery Systems

• AI-enabled Imaging & Navigation

• 3-D Printed & Patient-specific Implants

• Other Emerging Technologies

By Disease

• Kidney Diseases

• Urological Cancer & BPH

• Urinary Stones (Urolithiasis)

• Pelvic Organ Prolapse

• Urinary Incontinence

• Other Diseases

By End-User

• Hospitals & Clinics

• Dialysis Centres

• Ambulatory Surgical Centres

• Home-care Settings

• Other End-Users

By Geography

• North America

• United States

• Canada

• Mexico

• Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

• Asia-Pacific

• China

• Japan

• India

• Australia

• South Korea

• Rest of Asia-Pacific

• Middle East and Africa

• GCC

• South Africa

• Rest of Middle East and Africa

• South America

• Brazil

• Argentina

• Rest of South America

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/urology-devices-market?utm_source=globenewswire

Urology Devices Market Competitive Outlook

The urology devices market features a mix of global medical device manufacturers and specialized companies focusing on innovation, product development, and strategic collaborations. Market participants are investing in advanced technologies, expanding product portfolios, and strengthening distribution networks to meet the growing demand for urological care solutions.

Major Companies in the Urology Devices Market include:

Check out related reports published by Mordor Intelligence:

Ophthalmic Devices Market Size - The ophthalmic devices market is expected to grow from USD 53.66 billion in 2026 to USD 73.62 billion by 2031, registering a CAGR of 6.53% during the forecast period. Growth is driven by the rising prevalence of eye disorders, the increasing aging population, and the growing demand for advanced diagnostic and surgical ophthalmic technologies.

Alcon Inc., Johnson & Johnson Vision Care, Lumibird Medical, Bausch + Lomb, and ZEISS Group are the major companies operating in this market.

Read more about companies in the ophthalmic devices market: https://www.mordorintelligence.com/industry-reports/opthalmic-devices-market/companies?utm_source=globenewswire

Cardiovascular Devices Market Trends - The cardiovascular devices market is estimated to grow from USD 64.71 billion in 2026 to USD 81.29 billion by 2031, registering a CAGR of 4.67% during the forecast period. Market expansion is supported by the increasing incidence of cardiovascular diseases, rising demand for minimally invasive procedures, and continuous advancements in cardiac device technologies.

Boston Scientific Corporation, Abbott, Medtronic, Edwards Lifesciences Corporation, and Cardinal Health are the major companies operating in this market.

Read more about companies in the cardiovascular devices market: https://www.mordorintelligence.com/industry-reports/global-cardiovascular-devices-market-industry/companies?utm_source=globenewswire

Prostate Cancer Market Share - The prostate cancer market is estimated at USD 25.73 billion in 2026 and is projected to reach USD 38.33 billion by 2031, growing at a CAGR of 8.29% during the forecast period. Growth is driven by increasing prevalence of prostate cancer, rising awareness and screening programs, and expanding adoption of advanced treatment and diagnostic options.

Bayer AG, AstraZeneca PLC, Sanofi-Aventis, Thermo Fisher Scientific, and F. Hoffmann-La Roche Ltd. are the major companies operating in this market.

Read more about companies in the prostate cancer market: https://www.mordorintelligence.com/industry-reports/global-prostate-cancer-market-industry/companies?utm_source=globenewswire

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.